Alternatively, another study indicated that the treatment with PARP6 inhibitors might cause apoptosis in breast cancer cells because PARP6 contributes to the maintenance of centrosome integrity in breast cancer cells via MARylation of checkpoint kinase 1 (Wang et al., 2018). This evidence concerns the gene PARP6 and breast carcinoma.